Cargando…

Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome

Objectives: Pediatric acute-onset neuropsychiatric syndrome (PANS) is a clinical diagnosis in children who have an acute manifestation of varied neuropsychiatric symptoms, including obsessive compulsive disorder, eating disorders, tics, anxiety, irritability, and problems with attention/concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melamed, Isaac, Kobayashi, Roger H., O'Connor, Maeve, Kobayashi, Ai Lan, Schechterman, Andrew, Heffron, Melinda, Canterberry, Sharon, Miranda, Holly, Rashid, Nazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984935/ https://www.ncbi.nlm.nih.gov/pubmed/33601937 http://dx.doi.org/10.1089/cap.2020.0100

Ejemplares similares

Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study
por: Melamed, Isaac R., et al.
Publicado: (2021)

Intravenous immunoglobulin treatment improves multiple neuropsychiatric outcomes in patients with pediatric acute-onset neuropsychiatric syndrome
por: Eremija, Jelena, et al.
Publicado: (2023)

Attention Deficit Disorder and Allergic Rhinitis: Are They Related?
por: Melamed, Isaac, et al.
Publicado: (2016)

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease
por: Wasserman, Richard L., et al.
Publicado: (2016)

Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study
por: Borte, Michael, et al.
Publicado: (2017)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children
por: Hajjari, Parisa, et al.
Publicado: (2022)

Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies
por: Kobayashi, Roger H., et al.
Publicado: (2019)

Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig(®)]) in the treatment of patients with primary immunodeficiencies
por: Kobayashi, Roger H., et al.
Publicado: (2022)

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin
por: Kobayashi, T, et al.
Publicado: (2009)

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig(®)) in the treatment of patients with primary immunodeficiencies
por: Kobayashi, Roger H, et al.
Publicado: (2022)

Adult-Onset Immunoglobulin A Vasculitis With Renal Involvement
por: Khor, Si Yuan, et al.
Publicado: (2022)

Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
por: Gupta, Sudhir, et al.
Publicado: (2023)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Recalcitrant, delayed pressure urticaria treated with long-term intravenous immunoglobulin
por: Soliman, Yssra S., et al.
Publicado: (2020)

Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease
por: Yokoyama, Koji, et al.
Publicado: (2019)

Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients
por: Manganotti, Paolo, et al.
Publicado: (2021)

Early onset of scleromyxedema Arndt‐Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
por: Kefi, Asma, et al.
Publicado: (2022)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Intravenous Immunoglobulin: Revisited – My Experience
por: Vaishampayan, Sanjeev S., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
por: Stinca, Sara, et al.
Publicado: (2021)

Cytokines and Chemokines in Neuropsychiatric Syndromes of Systemic Lupus Erythematosus
por: Okamoto, Hiroshi, et al.
Publicado: (2010)

Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus
por: Khajezadeh, Mohammad-Amin, et al.
Publicado: (2018)

Copy Number Variations in Adult-onset Neuropsychiatric Diseases
por: Lew, Alexandra R., et al.
Publicado: (2018)

Pediatric Acute-Onset Neuropsychiatric Syndrome with Capgras Syndrome
por: Sharawat, Indar Kumar, et al.
Publicado: (2021)

Predicting Psychopathological Onset: Early Signs of Neuropsychiatric Diseases
por: Costanzi, Marco
Publicado: (2022)

Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
por: Gagliano, Antonella, et al.
Publicado: (2023)

Comparison of cognitive and neuropsychiatric profiles in hospitalised elderly medical patients with delirium, dementia and comorbid delirium–dementia
por: Leonard, Maeve, et al.
Publicado: (2016)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy
por: van der Pol, W.-Ludo, et al.
Publicado: (2010)

Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013)

Intravenous immunoglobulin and Alzheimer’s disease: what now?
por: Loeffler, David A
Publicado: (2013)

541 Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency
por: Oropeza, Said Arablin, et al.
Publicado: (2012)

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
por: Jønch, Aia Elise, et al.
Publicado: (2012)

The Production Processes and Biological Effects of Intravenous Immunoglobulin
por: Barahona Afonso, Ana Filipa, et al.
Publicado: (2016)

Bilateral uveitis following intravenous immunoglobulin administration
por: Kocak, Enis D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1lgl2khnea4rmoj3bvbgu326ga